{
  "experiment_info": {
    "experiment_name": "paper_22_Discovering_Novel",
    "run_number": 5,
    "total_runs": 10,
    "timestamp": "20250624_020624",
    "run_start_time": "2025-06-24T04:17:17.933186",
    "run_end_time": "2025-06-24T04:17:59.317952"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T04:17:17.934190",
      "data": {
        "description": "Solid tumors must recruit new blood vessels for growth and maintenance. Discovering drugs that block this tumor-induced development of new blood vessels (angiogenesis) is an important approach in cancer treatment. However, the complexity of angiogenesis and the difficulty in implementing and evaluating rationally-designed treatments prevent the discovery of effective new therapies. This paper presents a massively parallel computational search-based approach for the discovery of novel potential cancer treatments using a high fidelity simulation of angiogenesis. Discovering new therapies is viewed as multi-objective combinatorial optimization over two competing objectives: minimizing the cost of developing the intervention while minimizing the oxygen provided to the cancer tumor by angiogenesis. Results show the effectiveness of the search process in finding interventions that are currently in use and more interestingly, discovering some new approaches that are counter intuitive yet effective."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T04:17:37.903047",
      "prompt": "Original description: Solid tumors must recruit new blood vessels for growth and maintenance. Discovering drugs that block this tumor-induced development of new blood vessels (angiogenesis) is an important approach in cancer treatment. However, the complexity of angiogenesis and the difficulty in implementing and evaluating rationally-designed treatments prevent the discovery of effective new therapies. This paper presents a massively parallel computational search-based approach for the discovery of novel potential cancer treatments using a high fidelity simulation of angiogenesis. Discovering new therapies is viewed as multi-objective combinatorial optimization over two competing objectives: minimizing the cost of developing the intervention while minimizing the oxygen provided to the cancer tumor by angiogenesis. Results show the effectiveness of the search process in finding interventions that are currently in use and more interestingly, discovering some new approaches that are counter intuitive yet effective.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, I need to create a structured JSON object with ontology annotations based on the provided information. The user wants CellOntology, GeneOntology, and MeSH terms where applicable. Let me go through the original description step by step.\n\nThe main topic here is angiogenesis in solid tumors. The paper talks about tumor-induced angiogenesis and drug discovery to block it. So first, CellOntology. What cell types are involved in angiogenesis? Endothelial cells are key players in forming blood vessels. So maybe \"Endothelial Cell\" with CL ID. Let me check the exact term. Cell Ontology has \"endothelial cell\" as CL:0000115. Wait, the example uses \"Epithelial\" with a capital E, so I should capitalize \"Endothelial Cell\". But I need to confirm the exact term from Cell Ontology. Let me verify. Yes, the term is \"endothelial cell\" with lowercase in the ontology, but the example shows \"Epithelial\" capitalized. Hmm, maybe the user expects the term to be capitalized as in the example. Wait, the instruction says term names must be exact. So I need to check the exact spelling. Looking up CL:0000115, the official name is \"endothelial cell\". But the example uses \"Epithelial\" with a capital E, which might be incorrect. But according to the user's instructions, term names must be exact. So perhaps \"endothelial cell\" is correct. But the example shows \"Epithelial\" as the term. Maybe the user wants the terms to be capitalized as in typical usage, even if the ontology uses lowercase. This is a bit confusing. Wait, the user's example shows \"Epithelial\" and \"Mesenchymal\" both capitalized. Maybe they expect the first letter to be capitalized regardless of the ontology's actual case. Alternatively, maybe the ontology terms are case-insensitive. Hmm, but the instruction says \"term names must be exact without extra spaces\". So I need to use the exact term as per the ontology. Let me check. Looking up CL:0000115, the label is \"endothelial cell\" (lowercase). But perhaps in practice, people capitalize it. However, the user's example shows \"Epithelial\" which is correct as CL:0000066 is \"epithelial cell\", but in the example, it's written as \"Epithelial\". Wait, maybe the user is truncating the term. For example, \"epithelial cell\" in CL is the full term, but the example uses \"Epithelial\". That might be a mistake. But according to the instructions, the term must be exact. So if the ontology term is \"endothelial cell\", then the term should be exactly that. But the example shows \"Epithelial\" instead of \"epithelial cell\". This discrepancy is a problem. The user might have made a mistake in the example. But I need to follow the instructions strictly. The user says \"term names must be exact without extra spaces\". So I should use the exact term from the ontology. Therefore, for endothelial cells, the term is \"endothelial cell\" with CL:0000115. But maybe the user expects \"Endothelial Cell\" with capitals. Hmm, this is a conflict. Since the example shows \"Epithelial\" which is not the exact term (the exact term is \"epithelial cell\"), perhaps the user is using a shorthand. Alternatively, maybe the user is referring to a more general term. Alternatively, maybe the user wants the term as \"Endothelial\" without \"cell\". Wait, but in Cell Ontology, the terms are specific. Let me check. Searching Cell Ontology for \"endothelial\", the term is \"endothelial cell\" (CL:0000115). There's also \"endothelial progenitor cell\" (CL:0002619), but that's different. So the correct term here is \"endothelial cell\". But in the example, the user wrote \"Epithelial\" instead of \"epithelial cell\". So maybe they want the cell type name without \"cell\"? That would be incorrect, but perhaps it's a typo. Given the confusion, I'll proceed with the exact term from the ontology. So CellOntology entry would be \"endothelial cell\" with CL:0000115.\n\nNext, GeneOntology. The process involved here is angiogenesis. The relevant GO terms would be \"angiogenesis\" (GO:0001525) and possibly \"blood vessel morphogenesis\" (GO:0048514). Also, the paper mentions blocking angiogenesis, so maybe \"negative regulation of angiogenesis\" (GO:0016525). Let's confirm. The GO term for angiogenesis is GO:0001525. Yes. So including that. Also, the simulation involves oxygen transport, so maybe \"oxygen transport\" (GO:0015671), but the main focus is on angiogenesis. The intervention aims to minimize oxygen provided to the tumor via angiogenesis, so perhaps \"regulation of angiogenesis\" (GO:0045765) or \"negative regulation of angiogenesis\". The exact term for negative regulation is GO:0016525. So including that. Also, the paper mentions drug discovery, which might relate to \"response to drug\" (GO:0042493), but not sure if that's relevant here. The main GO terms would be angiogenesis-related.\n\nFor MeSH terms, the relevant ones would be \"Neovascularization, Pathologic\" (MeSH D018908), which is the term for pathological angiogenesis like in tumors. Also, \"Antineoplastic Agents\" (D000970) since the paper is about cancer treatments. Another possible term is \"Drug Discovery\" (D000067202), but MeSH ID for Drug Discovery is D004195. Wait, checking MeSH: Drug Discovery is D004195. Also, \"Angiogenesis Inhibitors\" (D019158) would be relevant. So including those.\n\nPutting this all together, the CellOntology entry is endothelial cell (CL:0000115). GeneOntology includes angiogenesis (GO:0001525) and negative regulation of angiogenesis (GO:0016525). MeSH terms would be Neovascularization, Pathologic (D018908), Angiogenesis Inhibitors (D019158), and Antineoplastic Agents (D000970). Need to ensure the IDs are correct and terms are exact. Double-checking:\n\n- CL:0000115: endothelial cell (correct)\n- GO:0001525: angiogenesis\n- GO:0016525: negative regulation of angiogenesis\n- MeSH D018908: Neovascularization, Pathologic\n- MeSH D019158: Angiogenesis Inhibitors\n- MeSH D000970: Antineoplastic Agents\n\nYes, those are correct. Now format the JSON exactly as specified, with the correct category names and no extra spaces. Capitalization for MeSH terms: MeSH terms are in title case, like \"Neovascularization, Pathologic\". So the JSON should have those exact terms.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0000115\",\n            \"term\": \"endothelial cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0001525\",\n            \"term\": \"angiogenesis\"\n        },\n        {\n            \"id\": \"GO:0016525\",\n            \"term\": \"negative regulation of angiogenesis\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D018908\",\n            \"term\": \"Neovascularization, Pathologic\"\n        },\n        {\n            \"id\": \"D019158\",\n            \"term\": \"Angiogenesis Inhibitors\"\n        },\n        {\n            \"id\": \"D000970\",\n            \"term\": \"Antineoplastic Agents\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T04:17:59.239192",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'endothelial cell (CL:0000115)'}, 'GeneOntology': {'angiogenesis (GO:0001525)', 'negative regulation of angiogenesis (GO:0016525)'}, 'MeSH': {'Angiogenesis Inhibitors (D019158)', 'Antineoplastic Agents (D000970)', 'Neovascularization, Pathologic (D018908)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a valid CompuCell3D simulation Python file based on the given ontology annotations. Let me break down the requirements.\n\nFirst, the user wants the code to include required imports, a simulation class that inherits from SteppableBasePy, and the __init__, start, and step methods. Also, basic cell types and parameters based on the provided ontologies.\n\nThe ontology annotations mention endothelial cells, angiogenesis, negative regulation of angiogenesis, Angiogenesis Inhibitors, Antineoplastic Agents, and Pathologic Neovascularization. So the simulation should involve endothelial cells and perhaps some inhibitors affecting their behavior.\n\nStarting with the imports. I know CompuCellSetup and steppables are necessary. Also, might need to import core modules for volume, contact, chemotaxis, etc.\n\nNext, the simulation class. It should inherit from SteppableBasePy. The __init__ method needs to call the parent's __init__. The start method is for initial setup, like setting up cell types and fields. The step method will handle actions each simulation step.\n\nFor cell types, the main one is endothelial cells. Maybe also a tumor cell type since Antineoplastic Agents are mentioned, which are cancer drugs. Or perhaps the inhibitors are chemical fields affecting endothelial cells.\n\nParameters based on the ontologies: Angiogenesis involves endothelial cell migration and proliferation. Negative regulation could mean inhibitors reduce these behaviors. So maybe set up a chemical field for inhibitors that endothelial cells respond to via chemotaxis, but the inhibitor negatively affects their movement or growth.\n\nIn the start method, define endothelial cell type and maybe a tumor type. Set up a chemical field 'inhibitor' that's secreted by tumor cells or something. Then configure the volume and contact energy constraints.\n\nIn the step method, maybe adjust the chemotaxis parameters based on the presence of inhibitors. For example, if the inhibitor concentration is high, endothelial cells move away or slow down.\n\nAlso, Antineoplastic Agents might be another chemical field that affects cell viability. So maybe introduce a drug that kills cells.\n\nWait, the MeSH terms include Angiogenesis Inhibitors and Antineoplastic Agents. So perhaps two chemical fields: 'inhibitor' and 'drug'. Endothelial cells could be chemotactic towards a growth factor (promoting angiogenesis) but repelled by the inhibitor. The drug (Antineoplastic) might kill tumor cells.\n\nBut the user's ontology is focused on endothelial cells and the negative regulation. Maybe the simulation has endothelial cells migrating, but inhibited by the inhibitor. The step method could apply the inhibitor effect each step.\n\nAlso, for basic parameters, set cell volume, adhesion parameters, maybe chemotaxis strength.\n\nPutting this all together: the code will define endothelial cells, set up volume and contact constraints, add a chemical field for the inhibitor, and in the step method, apply chemotaxis based on the inhibitor concentration. Maybe endothelial cells move away from high inhibitor areas, thus inhibiting angiogenesis.\n\nNeed to make sure the code is syntactically correct. Use CompuCellSetup.registerSteppable to register the steppable class. Define the cell types in the start method, set up the chemical field, and configure the plugins like VolumePlugin, ContactPlugin, ChemotaxisPlugin.\n\nWait, in CompuCell3D, chemical fields are usually set up using the ChemicalField plugin or via PDE solvers. But for simplicity, maybe use a uniform field or a gradient. Alternatively, use the FlexibleDiffusionSolverFE for the inhibitor.\n\nBut perhaps the user just wants a basic setup. So include the necessary plugins and steppables.\n\nSo the code outline would be:\n\nImports: CompuCellSetup, steppables, core plugins.\n\nSimulation class with __init__, start, step.\n\nIn start: define cell types (Endothelial, maybe Tumor), set volume and contact parameters, set up chemical field, configure chemotaxis.\n\nIn step: maybe adjust something each step, like secreting inhibitor or updating chemotaxis.\n\nTesting if this aligns with the ontology terms. Angiogenesis (endothelial cells growing/migrating), negative regulation via inhibitors, Antineoplastic agents as drugs, pathologic neovascularization (abnormal blood vessel growth).\n\nSo, the simulation could model endothelial cells migrating towards a signal (like VEGF), but inhibited by the inhibitor. The inhibitor's concentration affects their chemotactic behavior.\n\nIn code:\n\n- In start, create Endothelial cell type, set volume parameters (target volume, lambda), contact energy between cells.\n\n- Add a chemical field 'inhibitor' using AddChemicalFieldContainer.\n\n- Set up Chemotaxis by adding a chemical field to the plugin, then set chemotaxis parameters for Endothelial cells towards the inhibitor with a negative lambda (move away).\n\n- In step, maybe have the inhibitor concentration increase over time or based on conditions.\n\nBut the exact details might vary. The key is to include the necessary elements based on the ontologies.\n\nPutting it all together into code.\n</think>\n\n```python\nfrom pycells3 import CompuCellSetup\nfrom pycells3 import core\nfrom pycells3 import steppables\n\nclass AngiogenesisSimulation(steppables.SteppableBasePy):\n    def __init__(self, simulator):\n        super().__init__(simulator)\n        \n    def start(self):\n        self.configure_cell_types()\n        self.setup_plugins()\n        self.initialize_fields()\n        \n    def configure_cell_types(self):\n        self.endothelial_type = self.add_cell_type(\"Endothelial\")\n        self.tumor_type = self.add_cell_type(\"Tumor\")\n        \n        vol_params = core.VolumePluginParams(\n            target_volume=25,\n            lambda_volume=2.0\n        )\n        self.set_volume_parameters(self.endothelial_type, vol_params)\n        \n        contact_params = core.ContactPluginParams(\n            neighbor_order=2,\n            energy_matrix={\n                (self.endothelial_type, self.endothelial_type): 10,\n                (self.endothelial_type, self.tumor_type): 15\n            }\n        )\n        self.set_contact_energy_parameters(contact_params)\n        \n    def setup_plugins(self):\n        self.chemotaxis_plugin = self.add_chemotaxis_plugin()\n        self.inhibitor_field = self.add_chemical_field(\"Inhibitor\")\n        \n        chemotaxis_params = core.ChemotaxisParams(\n            chemical_field=self.inhibitor_field,\n            lambda_chemo=-0.5  # Negative chemotaxis away from inhibitor\n        )\n        self.chemotaxis_plugin.set_parameters(self.endothelial_type, chemotaxis_params)\n        \n    def initialize_fields(self):\n        self.inhibitor_field[:, :, :] = 0.0  # Initialize inhibitor concentration\n        \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.secrete_inhibitor()\n            \n    def secrete_inhibitor(self):\n        for cell in self.cell_list:\n            if cell.type == self.tumor_type:\n                x, y, z = cell.x, cell.y, cell.z\n                self.inhibitor_field[x, y, z] += 0.1  # Tumor cells secrete inhibitor\n\nCompuCellSetup.register_steppable(AngiogenesisSimulation)\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a valid CompuCell3D simulation Python file based on the given ontology annotations. Let me break down the requirements.\n\nFirst, the user wants the code to include required imports, a simulation class that inherits from SteppableBasePy, and the __init__, start, and step methods. Also, basic cell types and parameters based on the provided ontologies.\n\nThe ontology annotations mention endothelial cells, angiogenesis, negative regulation of angiogenesis, Angiogenesis Inhibitors, Antineoplastic Agents, and Pathologic Neovascularization. So the simulation should involve endothelial cells and perhaps some inhibitors affecting their behavior.\n\nStarting with the imports. I know CompuCellSetup and steppables are necessary. Also, might need to import core modules for volume, contact, chemotaxis, etc.\n\nNext, the simulation class. It should inherit from SteppableBasePy. The __init__ method needs to call the parent's __init__. The start method is for initial setup, like setting up cell types and fields. The step method will handle actions each simulation step.\n\nFor cell types, the main one is endothelial cells. Maybe also a tumor cell type since Antineoplastic Agents are mentioned, which are cancer drugs. Or perhaps the inhibitors are chemical fields affecting endothelial cells.\n\nParameters based on the ontologies: Angiogenesis involves endothelial cell migration and proliferation. Negative regulation could mean inhibitors reduce these behaviors. So maybe set up a chemical field for inhibitors that endothelial cells respond to via chemotaxis, but the inhibitor negatively affects their movement or growth.\n\nIn the start method, define endothelial cell type and maybe a tumor type. Set up a chemical field 'inhibitor' that's secreted by tumor cells or something. Then configure the volume and contact energy constraints.\n\nIn the step method, maybe adjust the chemotaxis parameters based on the presence of inhibitors. For example, if the inhibitor concentration is high, endothelial cells move away or slow down.\n\nAlso, Antineoplastic Agents might be another chemical field that affects cell viability. So maybe introduce a drug that kills cells.\n\nWait, the MeSH terms include Angiogenesis Inhibitors and Antineoplastic Agents. So perhaps two chemical fields: 'inhibitor' and 'drug'. Endothelial cells could be chemotactic towards a growth factor (promoting angiogenesis) but repelled by the inhibitor. The drug (Antineoplastic) might kill tumor cells.\n\nBut the user's ontology is focused on endothelial cells and the negative regulation. Maybe the simulation has endothelial cells migrating, but inhibited by the inhibitor. The step method could apply the inhibitor effect each step.\n\nAlso, for basic parameters, set cell volume, adhesion parameters, maybe chemotaxis strength.\n\nPutting this all together: the code will define endothelial cells, set up volume and contact constraints, add a chemical field for the inhibitor, and in the step method, apply chemotaxis based on the inhibitor concentration. Maybe endothelial cells move away from high inhibitor areas, thus inhibiting angiogenesis.\n\nNeed to make sure the code is syntactically correct. Use CompuCellSetup.registerSteppable to register the steppable class. Define the cell types in the start method, set up the chemical field, and configure the plugins like VolumePlugin, ContactPlugin, ChemotaxisPlugin.\n\nWait, in CompuCell3D, chemical fields are usually set up using the ChemicalField plugin or via PDE solvers. But for simplicity, maybe use a uniform field or a gradient. Alternatively, use the FlexibleDiffusionSolverFE for the inhibitor.\n\nBut perhaps the user just wants a basic setup. So include the necessary plugins and steppables.\n\nSo the code outline would be:\n\nImports: CompuCellSetup, steppables, core plugins.\n\nSimulation class with __init__, start, step.\n\nIn start: define cell types (Endothelial, maybe Tumor), set volume and contact parameters, set up chemical field, configure chemotaxis.\n\nIn step: maybe adjust something each step, like secreting inhibitor or updating chemotaxis.\n\nTesting if this aligns with the ontology terms. Angiogenesis (endothelial cells growing/migrating), negative regulation via inhibitors, Antineoplastic agents as drugs, pathologic neovascularization (abnormal blood vessel growth).\n\nSo, the simulation could model endothelial cells migrating towards a signal (like VEGF), but inhibited by the inhibitor. The inhibitor's concentration affects their chemotactic behavior.\n\nIn code:\n\n- In start, create Endothelial cell type, set volume parameters (target volume, lambda), contact energy between cells.\n\n- Add a chemical field 'inhibitor' using AddChemicalFieldContainer.\n\n- Set up Chemotaxis by adding a chemical field to the plugin, then set chemotaxis parameters for Endothelial cells towards the inhibitor with a negative lambda (move away).\n\n- In step, maybe have the inhibitor concentration increase over time or based on conditions.\n\nBut the exact details might vary. The key is to include the necessary elements based on the ontologies.\n\nPutting it all together into code.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nfrom pycells3 import CompuCellSetup\nfrom pycells3 import core\nfrom pycells3 import steppables\n\nclass AngiogenesisSimulation(steppables.SteppableBasePy):\n    def __init__(self, simulator):\n        super().__init__(simulator)\n        \n    def start(self):\n        self.configure_cell_types()\n        self.setup_plugins()\n        self.initialize_fields()\n        \n    def configure_cell_types(self):\n        self.endothelial_type = self.add_cell_type(\"Endothelial\")\n        self.tumor_type = self.add_cell_type(\"Tumor\")\n        \n        vol_params = core.VolumePluginParams(\n            target_volume=25,\n            lambda_volume=2.0\n        )\n        self.set_volume_parameters(self.endothelial_type, vol_params)\n        \n        contact_params = core.ContactPluginParams(\n            neighbor_order=2,\n            energy_matrix={\n                (self.endothelial_type, self.endothelial_type): 10,\n                (self.endothelial_type, self.tumor_type): 15\n            }\n        )\n        self.set_contact_energy_parameters(contact_params)\n        \n    def setup_plugins(self):\n        self.chemotaxis_plugin = self.add_chemotaxis_plugin()\n        self.inhibitor_field = self.add_chemical_field(\"Inhibitor\")\n        \n        chemotaxis_params = core.ChemotaxisParams(\n            chemical_field=self.inhibitor_field,\n            lambda_chemo=-0.5  # Negative chemotaxis away from inhibitor\n        )\n        self.chemotaxis_plugin.set_parameters(self.endothelial_type, chemotaxis_params)\n        \n    def initialize_fields(self):\n        self.inhibitor_field[:, :, :] = 0.0  # Initialize inhibitor concentration\n        \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.secrete_inhibitor()\n            \n    def secrete_inhibitor(self):\n        for cell in self.cell_list:\n            if cell.type == self.tumor_type:\n                x, y, z = cell.x, cell.y, cell.z\n                self.inhibitor_field[x, y, z] += 0.1  # Tumor cells secrete inhibitor\n\nCompuCellSetup.register_steppable(AngiogenesisSimulation)",
      "output_file": "experiments\\batch_reasoning_20250624_020624\\paper_22_Discovering_Novel_20250624_020624\\run_5\\generated_cc3d_model.cc3d"
    }
  }
}